For the Quarter Ending March 2026
Cephalexin Prices in APAC
- In China, the Cephalexin Price Index rose by 3.86% quarter-over-quarter, supported by stronger export demand.
- The average Cephalexin price for the quarter was approximately USD 53333.33/MT, reflecting modest export-weighted levels.
- Cephalexin Spot Price movements remained contained while the Price Index reflected month-end tightening at ports.
- Cephalexin Price Forecast indicates moderate gains into April as restocking and tender schedules support upward revisions.
- Cephalexin Production Cost Trend rose due to higher coal-fired steam tariffs and wastewater-treatment compliance costs.
- Cephalexin Demand Outlook remains export-led with Indian, Brazilian, and Indonesian tenders sustaining incremental procurement volumes.
- Cephalexin Price Index gains were amplified by constrained merchant availability and pre-announced maintenance, reducing spot offers.
- Inventories stayed around two weeks cover while vertically integrated producers maintained near-nameplate operating rates this quarter.
Why did the price of Cephalexin change in March 2026 in APAC?
- Constrained merchant availability and GMP recertification batches limited spot offers, tightening short-term exportable supply levels.
- Robust public-sector tendering from India, Brazil, and Indonesia increased replacement buying, supporting stronger export-driven pricing.
- Higher coal-fired steam tariffs and wastewater-treatment fees added cost-push pressure to producers' cash-cost bases modestly.
Cephalexin Prices in Europe
- In Germany, the Cephalexin Price Index rose by 3.89% quarter-over-quarter, reflecting tighter Asian export offers.
- The average Cephalexin price for the quarter was approximately USD 53458.00/MT, reported by Hamburg importers.
- Reduced export availability pushed Cephalexin Spot Price higher, tightening German wholesaler inventories and prompting buying.
- Cephalexin Price Forecast indicates modest gains as importers cover lean stocks ahead of spring production.
- Rising energy and fermentation inputs supported an uptick in Cephalexin Production Cost Trend for exporting manufacturers.
- German hospital tenders and retail prescriptions strengthened Cephalexin Demand Outlook in March, sustaining import pull.
- Wholesaler stock rebuilding and tender schedules lifted the Cephalexin Price Index, accentuating short-term market tightness.
- Asian plant maintenance, allocation discipline constrained supplies, pressuring landed cost,s and strengthening German buying urgency.
Why did the price of Cephalexin change in March 2026 in Europe?
- Reduced Asian spot parcels and one inspection-delayed release materially tightened availability for Hamburg importers urgently.
- Pharmacy and hospital restocking ahead of spring tenders amplified buying, sustaining price upside in March.
- Higher energy-linked fermentation costs and elevated freight plus war-risk insurance supported landed cost increases notably.
Cephalexin Prices in North America
- In the USA, the Cephalexin Price Index rose by 3.84% quarter-over-quarter, reflecting tighter imports and compliance.
- The average Cephalexin price for the quarter was approximately USD 53512.00/MT, reflecting logistics and compliance.
- Cephalexin Spot Price held steady; the Price Index showed volatility amid ample imports and inventory
- Cephalexin Price Forecast expects gains as the Cephalexin Production Cost Trend firmed from feedstock increases
- Cephalexin Demand Outlook remains positive with hospital and retail prescriptions supporting replenishment and distributor buying
- March Cephalexin Price Index rose as exporters tightened allocations and U.S. distributors replenished inventories seasonally
- Higher war-risk insurance and freight elevated landed costs, reinforcing the Cephalexin Production Cost Trend, and offers
- Market liquidity remained adequate, limiting volatility; the Cephalexin Price Forecast assumes stable imports and buying
Why did the price of Cephalexin change in March 2026 in North America?
- Tighter export allocations from India and Europe reduced import availability, driving higher landed costs in March
- Firm 7-ADCA feedstock prices and higher compliance expenses raised Cephalexin Production Cost Trend and offers
- U.S. distributors accelerated replenishment for seasonal demand and formulary updates, tightening inventories and firming pricing
For the Quarter Ending December 2025
Cephalexin Price in APAC
- In China, the Cephalexin Price Index rose by 0.51% quarter-over-quarter, mildly reflecting post-holiday restocking activity.
- The average Cephalexin price for the quarter was approximately USD 51351.33/MT, reflecting inventory normalization nationally.
- Cephalexin Spot Price firmed slightly as hospitals and formulators replenished stocks amid seasonal respiratory prescriptions.
- Cephalexin Price Forecast shows modest upside into Q1 driven by restocking and supplier inventory management.
- Cephalexin Production Cost Trend remained muted as intermediates and coal-linked utility tariffs held broadly unchanged.
- Cephalexin Demand Outlook improved modestly with year-end tenders and steady export enquiries supporting additional offtake.
- Logistics stability and integrated feedstock supply helped stabilize the Cephalexin Price Index during December shipments.
- Producers maintained high operating rates, enabling shipments and limiting volatility in the Cephalexin Price Index.
Why did the price of Cephalexin change in December 2025 in APAC?
- Export enquiries firmed before year-end tenders, increasing short-term offtake and slightly narrowing spot availability overall.
- Upstream feedstock flows remained uninterrupted and input pricing stable, preventing significant production cost increases during.
- Shanghai port operations and inland logistics normalized, enabling timely shipments and avoiding supply-side disruptions to prices.
Cephalexin Price in Europe
- In Germany, the Cephalexin Price Index rose by 0.5% quarter-over-quarter, due to marginally firmer Indian-origin offers and lean wholesaler inventories.
- The average Cephalexin price for the quarter was approximately USD 55323.33/MT, reflecting marginal firmness across import sources.
- German Cephalexin Spot Price activity stayed narrow, with limited volatility amid steady Asian export flows and logistics relief.
- Cephalexin Price Forecast indicates modest month-to-month gains supported by year-end procurement and controlled supply tightness.
- Cephalexin Production Cost Trend shows upward pressure from feedstock and container handling, partially offset by stable freight rates.
- Cephalexin Demand Outlook remains steady, driven by hospital and outpatient procurement but constrained by rebate-driven purchasing behaviors.
- Cephalexin Price Index movements reflected balanced inventories, efficient Hamburg operations, and mixed currency effects on landed costs.
- Export redistribution to neighbors and absence of disruptions maintained market continuity, keeping offers cautiously firm across the quarter.
Why did the price of Cephalexin change in December 2025 in Europe?
- Marginally higher Indian-origin offers combined with lean wholesaler inventories nudged landed costs higher in December.
- Container booking costs ticked up slightly, increasing delivered cost base despite broadly stable freight rates.
- Statutory rebate ceilings limited pass-through, tempering stronger price increases despite modest supply tightening in Germany.
Cephalexin Price in North America
- In USA, the Cephalexin Price Index rose by 0.62% quarter-over-quarter, procurement and tighter European allocations.
- The average Cephalexin price for the quarter was approximately USD 55375.00/MT, per major distributors' averages.
- Cephalexin Spot Price remained thin as distributors replenished lower inventories, keeping Cephalexin Price Index stable.
- Cephalexin Price Forecast indicates modest upside into early 2026 driven by seasonality and restocking activity.
- Cephalexin Production Cost Trend reflected higher Asian offers for feedstock and freight driving upward pressure.
- Cephalexin Demand Outlook remains broadly constructive with winter prescribing and veterinary restocking underpinning procurement activity.
- Lower trans-Pacific freight and stable currency reduced landed costs, yet Cephalexin Price Index preserved firmness.
- European allocation discipline and four-to-six week lead times tightened offers, influencing Cephalexin Spot Price availability.
Why did the price of Cephalexin change in December 2025 in North America?
- Tighter European export allocations and purchasing increased landed costs, reducing spot cargoes to US importers.
- Freight easing offset offers, but higher Asian feedstock quotations and allocation raised import pricing pressure.
- Steady winter prescription volumes and distributor restocking depleted inventories, supporting modest price gains through December.
For the Quarter Ending September 2025
North America
- In USA, the Cephalexin Price Index rose by 0.15% quarter-over-quarter, reflecting import costs and demand.
- The average Cephalexin price for the quarter was approximately USD 55031.67/MT, per official trade records.
- Elevated freight and currency moves constrained Cephalexin Spot Price while Cephalexin Price Index remained supportive.
- Declining landed costs yet persistent feedstock inflation moderated the Cephalexin Production Cost Trend and margins.
- Cephalexin Demand Outlook shows cautious restocking from API manufacturers due to elevated inventories and uncertainty.
- Short term Cephalexin Price Forecast suggests gradual softening then selective rebounds from year-end procurement activity.
- High domestic stocks depressed the Cephalexin Price Index while export enquiries provided intermittent support periodically.
- Major manufacturer run-rates remained stable, limiting supply shocks and keeping the Cephalexin Price Index rangebound.
Why did the price of Cephalexin change in September 2025 in North America?
- Higher European export offers and freight increases raised landed costs, tightening importer margins, pressuring prices.
- Elevated inventory levels and cautious restocking by downstream API formulators reduced buying urgency, softening demand.
- Currency fluctuations and easing freight rates altered procurement economics, creating mixed incentives across importers nationwide.
APAC
- In China, the Cephalexin Price Index rose by 0.14% quarter-over-quarter, reflecting supply and mixed demand.
- The average Cephalexin price for the quarter was approximately USD 54910.00/MT, reflecting market settlement levels.
- Cephalexin Spot Price eased as suppliers cleared inventories, pressuring offers despite stable production and logistics.
- Cephalexin Price Forecast indicates modest upside later in quarter supported by restocking and seasonal uptick.
- Rising raw material costs altered the Cephalexin Production Cost Trend, constraining price flexibility for exporters.
- Weak overseas orders shaped the Cephalexin Demand Outlook, while domestic pharmaceutical offtake remained comparatively steady.
- High inventories and stock clearance pressured the Cephalexin Price Index, constraining export quotations and margins.
- Stable plant operations and strategic restocking influenced offers, prompting analysts to revise the Cephalexin Price Index trajectory.
Why did the price of Cephalexin change in September 2025 in APAC?
- Production restarts increased availability after shutdowns, raising inventories and moderating spot differentials and export urgency.
- Continued raw material cost pressures and currency shifts influenced supplier margins, sustaining cautious pricing adjustments in September.
- Subdued overseas demand and accelerated domestic stock clearance reduced procurement activity, applying downward pressure on quotations.
Europe
- In Germany, the Cephalexin Price Index rose by 0.15% quarter-over-quarter, reflecting modest import and demand shifts.
- The average Cephalexin price for the quarter was approximately USD 55014.67/MT, according to CFR Hamburg data.
- Cephalexin Spot Price softened in August, pressured by ample inventories and lower Asian export quotations.
- Cephalexin Demand Outlook remained muted as API and healthcare formulators delayed restocking amid cautious procurement behavior.
- Cephalexin Production Cost Trend showed mixed signals with freight inflation offset by declining raw material costs.
- Cephalexin Price Forecast indicates modest volatility into autumn, balancing intermittent restocking against persistent inventory overhangs.
- Cephalexin Price Index movements tracked maritime freight fluctuations and Asian exporters' pricing strategies affecting landed costs.
- Domestic inventories remained elevated, limiting purchase urgency while export demand intermittently supported supplier price resilience.
Why did the price of Cephalexin change in September 2025 in Europe?
- Asian exporters moderated quotations while German buyers retained high inventories, softening procurement and price momentum.
- Freight volatility affected landed costs, creating import economics uncertainty that pressured pricing for German buyers.
- Mixed API and healthcare offtake tempered restocking decisions, limiting immediate buying despite improving manufacturing indicators.
For the Quarter Ending June 2025
North America
- The Cephalexin Price Index in North America increased steadily throughout Q2 2025, supported by firm import costs and consistent downstream pharmaceutical demand.
- Spot Price levels rose over the quarter, with June 2025 assessed at around USD 56,115/MT CFR Houston, reflecting a 1.81% rise compared to May.
- Prices were influenced by higher export offers from Europe, particularly Spain, as well as increased ocean freight charges and currency-driven cost inflation.
- The Cephalexin Production Cost Trend remained elevated due to expensive raw material imports and unfavorable Euro-USD exchange rates that drove up landed costs.
- The Cephalexin Demand Outlook was stable, with sustained offtake from API manufacturers and drug formulation units across the U.S. healthcare sector.
- In July 2025, the Price Index continued its upward trajectory, driven by tightening inventories, firm supplier quotations, and strong procurement from pharmaceutical distributors.
- Why did the price increase in July 2025?
Price gains were led by elevated shipping costs, restocking efforts, and limited spot availability from European suppliers amid stable demand.
- The Cephalexin Price Forecast indicates a potential for further increases into August if freight rates remain high and European production remains constrained.
Europe
- The Cephalexin Price Index in Germany increased consistently throughout Q2 2025, supported by strong pharmaceutical demand and rising landed costs from key supplying countries.
- Spot Price levels moved upward across the quarter, with June 2025 assessed at approximately USD 54,950/MT CFR Hamburg, reflecting a 1.78% increase over May levels.
- Prices were primarily influenced by elevated export offers from India and Spain, as well as rising container freight rates and firm supplier quotations amid tight global availability.
- The Cephalexin Production Cost Trend remained elevated due to higher input prices and unfavorable Euro-USD exchange movements, which inflated import expenses.
- The Cephalexin Demand Outlook remained firm in Germany’s pharmaceutical sector, with steady API and formulation orders driven by consistent prescription volumes and restocking activity.
- In July 2025, the Price Index continued its upward momentum, driven by a combination of strong buyer activity, lean inventory levels, and elevated replacement costs from Asia and Southern Europe.
- Why did the price increase in July 2025?
The uptick was led by robust downstream offtake, rising transportation charges, and reduced exporter allocations amid ongoing production constraints.
- The Cephalexin Price Forecast signals further bullishness through Q3 2025 if logistical tightness persists and Indian and European suppliers maintain firm export pricing.
APAC
- Price Index for June 2025 showed a notable increase in China, reflecting a 1.82% rise in spot price for Cephalexin (USP) FOB Shanghai due to constrained output and low inventories.
- Spot Price remained elevated as seasonal shutdown preparation and earlier production halts tightened supply, pushing suppliers to implement upward pricing.
- Price Forecast for July is expected to show continued firmness due to inventory shortages, export order backlogs, and peak-season manufacturing disruptions.
- Production Cost Trend remained stable; however, suppliers passed through currency-related margin pressures as the US Dollar depreciated against the Chinese Yuan
- Demand Outlook stayed bullish with strong offtake from pharmaceutical buyers both domestically and internationally, particularly in Southeast and South Asia
- The significant price increase was primarily driven by upstream production constraints and reduced material availability during the month.
- Suppliers responded to robust export interest and currency shifts by raising offer levels to maintain profitability amid tightening margins.
- Improved trade environment and streamlined logistics further supported order execution and bolstered pricing power for Chinese exporters.
- Inventory levels remained critically low, pressuring buyers to accept higher rates to secure uninterrupted supply during the transition to Q3 2025.
- Market sentiment in China remained optimistic as steady procurement and internal consumption support policies buoyed long-term price stability.
